↓ Skip to main content

Personalized peptide vaccination: a new approach for advanced cancer as therapeutic cancer vaccine

Overview of attention for article published in Cancer Immunology, Immunotherapy, November 2012
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (80th percentile)
  • Average Attention Score compared to outputs of the same age and source

Mentioned by

patent
5 patents

Citations

dimensions_citation
83 Dimensions

Readers on

mendeley
54 Mendeley
Title
Personalized peptide vaccination: a new approach for advanced cancer as therapeutic cancer vaccine
Published in
Cancer Immunology, Immunotherapy, November 2012
DOI 10.1007/s00262-012-1379-1
Pubmed ID
Authors

Masanori Noguchi, Tetsuro Sasada, Kyogo Itoh

Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 54 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Spain 1 2%
United States 1 2%
Russia 1 2%
Austria 1 2%
Unknown 50 93%

Demographic breakdown

Readers by professional status Count As %
Student > Ph. D. Student 15 28%
Student > Master 7 13%
Student > Bachelor 6 11%
Professor 5 9%
Researcher 4 7%
Other 10 19%
Unknown 7 13%
Readers by discipline Count As %
Medicine and Dentistry 14 26%
Agricultural and Biological Sciences 12 22%
Biochemistry, Genetics and Molecular Biology 6 11%
Pharmacology, Toxicology and Pharmaceutical Science 5 9%
Immunology and Microbiology 3 6%
Other 6 11%
Unknown 8 15%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 6. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 09 February 2023.
All research outputs
#4,876,759
of 23,468,283 outputs
Outputs from Cancer Immunology, Immunotherapy
#514
of 2,932 outputs
Outputs of similar age
#50,113
of 280,680 outputs
Outputs of similar age from Cancer Immunology, Immunotherapy
#7
of 16 outputs
Altmetric has tracked 23,468,283 research outputs across all sources so far. Compared to these this one has done well and is in the 76th percentile: it's in the top 25% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 2,932 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 5.2. This one has gotten more attention than average, scoring higher than 72% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 280,680 tracked outputs that were published within six weeks on either side of this one in any source. This one has done well, scoring higher than 80% of its contemporaries.
We're also able to compare this research output to 16 others from the same source and published within six weeks on either side of this one. This one is in the 37th percentile – i.e., 37% of its contemporaries scored the same or lower than it.